Flow Cytometry Market: Moving Towards a Brighter Future
Flow cytometry is a procedure based on laser technology employed in cell counting, cell sorting, protein engineering and biomarker detection. Flow cytometer are used in cytology, hematology, immunology, and microbiology, among other research fields. Advancements in the technology such as, the use of more robust photodetectors and new laser emitters, the use of LED lamps as emitter, and changes in analytical capacity in flow cytometry are expected to favor growth of the flow cytometry market. This technique allows researchers to get highly specific information about individual cells. The increasing application of flow cytometry in diagnostic test favors the market. For instance the CD4 test for HIV.
Get sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/1152
The global flow cytometry market was valued at US$ 3.2 Bn in 2016 and is expected to witness a robust CAGR of 10.2 % over the forecast period (2017-2025).
Increasing novel application of flow cytometer, such as cytogenomics, proteomics, and marine cell biology, is expected to drive the flow cytometry market in near future. Whereas, increasing demand for flow cytometry in hospitals and diagnostic centers for the effective diagnosis as well as monitoring of diseases supports the growth of market. Moreover, limited availability of technical expertise hampers the growth of flow cytometry market.
Increase in clinical applications of flow cytometry is expected to favor the flow cytometry market
The use of flow cytometry in clinical laboratory has grown substantially due to the development of smaller, user-friendly, less expensive instruments and increasing number of research application such as, immunophenotyping, cell sorting, cell cycle analysis, Apoptosis, cell proliferation assays, and intracellular calcium flux is expected to favor the growth of flow cytometry market. Besides, flow cytometry has a unique ability to investigate large cell populations at the single-cell level. This favors the adoption of flow cytometry for clinical application.
Furthermore, flow cytometry is also gaining attraction in drug discovery and development, which helps transforming every stage of preclinical and clinical development, that guide new product evaluation, selection and monitoring. Flow cytometry increases the probability of success in drug development and also allows for more informed decision making. The demand for flow cytometry is growing at all phases of development from early to late favoring the growth of flow cytometry use in industry for drug development process.
Flow cytometry is also employed in testing of CD4 count in order to treat HIV patients with suitable antiretroviral drugs. The BD Biosciences provides CD4 testing facilities and products. BD Biosciences has 3 different systems, namely, BD FACSCount system, mostly used in emerging economies, owing to its ease of use; the BD FACSCalibur system is used in large-volume labs where over 1,000,000 tests are performed annually, and the BD FACSCanto II system, used for HIV monitoring and other applications.
Ask for customization: https://www.coherentmarketinsights.com/insight/request-customization/1152
North America dominates the global flow cytometry market
North America accounts for the largest share in the global flow cytometry market, followed by Europe. This mainly is attributed to research and advancement in technology and wide acceptance of the flow cytometry and rapid growth of the life sciences sector in developed countries such as the U.S. The flow cytometry market is expected to show high growth rate in Asia-Pacific region over the forecast period supported by increasing prevalence of HIV. According to Joint United Nations Programme on HIV/AIDS (UNAIDS), 2016, around 49,00,000 HIV infected people aged 15 years and above were living in the Asia Pacific region, which in turn is expected to propel the market growth in Asia Pacific region.
Some major players operating in the flow cytometry market are Becton Dickinson and Company, General Electric Company, Luminex Corporation, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Miltenyi Biotec GmbH, Merck & Co Inc., Sysmex Corporation, Agilent Technologies, Inc. and Danaher Corporation.
You may be interested
Myeloproliferative Neoplasms Treatment Market – Current Trends and Future Opportunities by 2026Albert R - September 20, 2018
Coherent Market Insights added Latest Research Report titled “Myeloproliferative Neoplasms Treatment Market Insights by Manufacturers, Growth, Trends, Regions, Product Type and Application, Geography, Forecast to 2026” to…
Osteoarthritis Treatment Market – Competitive Insights, Significant Futuristic Trends and Opportunities 2026Albert R - September 20, 2018
Coherent Market Insights added Latest Research Report titled “Osteoarthritis Treatment Market Insights by Manufacturers, Growth, Trends, Regions, Product Type and Application, Geography, Forecast to 2026” to its…
Schistosomiasis Treatment Market Explore Future Growth 2018-2026 by Global Top PlayersAlbert R - September 20, 2018
Coherent Market Insights added Latest Research Report titled “Schistosomiasis Treatment Market Insights by Manufacturers, Growth, Trends, Regions, Product Type and Application, Geography, Forecast to 2026” to its…